Taiwan Starts Dosing Homegrown Vaccine Amid Import Challenges
Follows July EUA
Executive Summary
Taiwan's president the first to receive domestically developed vaccine which results so far suggest has high efficacy, amid multiple challenges for the local inoculation campaign.
You may also be interested in...
More Candidate COVID-19 Vaccines Expected To Enter WHO’s Global Trial
A new global clinical trial initiative is assessing a number of second-generation candidate vaccines for COVID-19. The Australian medicines regulator has given the go-ahead for an approval application for one of the vaccines, from Taiwan’s Medigen.
Fosun-BioNTech mRNA Vaccine Nears China Green Light
There is talk about offering booster shots to people who have already been fully vaccinated against COVID-19 in China and it’s increasingly clear that the mRNA vaccine from BioNTech/Fosun nearing approval could be the answer. Meanwhile, some Asian countries are turning away from Chinese coronavirus vaccines.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: another big deal in radiopharmaceuticals; BioNTech’s ADC pipeline; China CDMOs embrace uncertain future; at look at the rivals in MASH; and industry views on how AI might be transformative.